Child developmental issues: latest news

Child developmental issues resources

  • Education

    At the age of four or five your child will start going to school. This is initially an unsettling experience for a lot of children, but most...

    From: Booklets

    Information level Level 2
  • HIV & children

    This booklet provides information about treatment and care for children living with HIV. ...

    From: Booklets

    Information level Level 2

Child developmental issues features

Child developmental issues news from aidsmap

More news

Child developmental issues news selected from other sources

  • HIV-positive, exposed children have worse neurodevelopmental outcomes

    Children who are HIV-positive or have been exposed to the virus are at increased risk of having poorer outcomes regarding cognitive and motor development compared with children who are HIV-negative and have not been exposed, according to findings ...

    19 February 2018 | Healio
  • NIH Begins Large HIV Treatment Study in Pregnant Women

    The National Institutes of Health has launched a large international study to compare the safety and efficacy of three antiretroviral treatment regimens for pregnant women living with HIV and the safety of these regimens for their infants. The study will evaluate the current preferred first-line regimen for pregnant women recommended by the World Health Organization (WHO) and two regimens containing newer antiretroviral drugs that are becoming more widely used.

    24 January 2018 | NIAID press release
  • BHIVA response to BMJ article on ART in pregnant women living with HIV

    We do not support recommendations of "ART in pregnant women living with HIV: a clinical practice guideline" (BMJ, 11/9/17). Other systematic reviews and numerous observational studies show tenofovir to be safe in HIV in pregnancy.

    25 September 2017 | BHIVA
  • New recommendations aim to help pregnant women with HIV make informed choices

    New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

    12 September 2017 | EurekAlert
  • HIV—Pregnancy-related issues

    Themed issue of CATIE's magazine Treatment Update, with several articles on the safety of antiretrovirals during pregnancy.

    20 January 2015 | CATIE
  • Risk of birth defects small with HIV drugs

    The risks of birth defects in children exposed to antiretroviral drugs in utero are small when considering the clear benefit of preventing mother-to-child transmission of HIV but where there are safe and effective alternatives, it might be appropriate to avoid use by pregnant women of drugs that may be associated with elevated risks of birth defects, such as zidovudine and efavirenz, according to a study published by French researchers published in this week's PLOS Medicine.

    30 April 2014 | EurekAlert
  • HIV Drug Linked to Low Bone Density in Babies

    In a cohort study, babies of mothers taking tenofovir (Viread) had an average whole-body bone mineral content about 8 grams less than babies whose mothers did not use the drug, according to George Siberry, MD, of the National Institute of Child Health and Human Development in Bethesda, Md

    07 March 2014 | MedPage Today
  • Intrauterine, postnatal growth unaffected by exposure to HIV, antenatal antiretrovirals

    Exposure to HIV and antenatal antiretrovirals did not significantly affect infants’ intrauterine or early postnatal growth, according to study results published in The Pediatric Infectious Disease Journal.

    08 January 2014 | Healio
  • Improved caregiver training helps HIV-infected children

    Children born with HIV can live longer and richer lives if their caregivers receive training in ways to enhance the children’s development, according to research led by Michigan State University.

    15 August 2013 | Michigan State University (press release)
  • Anti-HIV drugs may protect against puberty delays in HIV-infected children

    For children who have been HIV-infected since birth, current anti-HIV drug regimens may protect against the delays in puberty that had been seen in HIV-infected children taking older regimens, according to researchers funded by the National Institutes of Health.

    15 August 2013 | National Institutes of Health (press release)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.